Market Cap (In USD)
28.94 Million
Revenue (In USD)
-
Net Income (In USD)
-2.09 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.25-3.5
- PE
- -
- EPS
- -
- Beta Value
- -2.7
- ISIN
- US76133Y1055
- CUSIP
- CIK
- 1836295
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Jerry Katzman
- Employee Count
- -
- Website
- https://retinalgenix.com
- Ipo Date
- 2022-02-24
- Details
- RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
More Stocks
-
SVV
-
002743
-
GLNGGolar LNG Limited
GLNG
-
2209
-
114090
-
002083Sunvim Group Co.,Ltd
002083
-
TRARFTeras Resources Inc.
TRARF
-
PSNPersimmon Plc
PSN